These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6258365)

  • 1. Simultaneous bilateral cancer of the brease--evaluation of the use of a contralateral biopsy.
    Andersen LI; Muchardt O
    Acta Chir Scand; 1980; 146(6):407-9. PubMed ID: 6258365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentric and bilateral appearance of lobular carcinoma in situ of the breast.
    Anderson JA
    Acta Pathol Microbiol Scand A; 1974 Nov; 82(6):730-4. PubMed ID: 4374873
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
    Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
    Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential for carcinoma existing synchronously on a microscopic level within the second breast.
    Fenig J; Arlen M; Livingston SF; Levowitz BS
    Surg Gynecol Obstet; 1975 Sep; 141(3):394-6. PubMed ID: 169600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal breast cancer: advance or anachronism?
    Wolmark N
    Can J Surg; 1985 May; 28(3):252-5. PubMed ID: 2986808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
    Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
    Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
    Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
    Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentricity and bilaterality in invasive breast carcinoma.
    Lesser ML; Rosen PP; Kinne DW
    Surgery; 1982 Feb; 91(2):234-40. PubMed ID: 6277027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma.
    Renshaw AA; Cartagena N; Derhagopian RP; Gould EW
    Am J Clin Pathol; 2002 May; 117(5):797-9. PubMed ID: 12090431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bilateral primary breast cancer. An analysis of 64 cases].
    Xue ZQ
    Zhonghua Wai Ke Za Zhi; 1992 May; 30(5):284-6, 317. PubMed ID: 1337736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between core biopsy and excisional biopsy in breast high-risk lesions.
    Margenthaler JA; Duke D; Monsees BS; Barton PT; Clark C; Dietz JR
    Am J Surg; 2006 Oct; 192(4):534-7. PubMed ID: 16978969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bilateral adenoma of nipple (author's transl)].
    Citoler P; Broer KH; Zippel HH
    Geburtshilfe Frauenheilkd; 1973 Sep; 33(9):729-31. PubMed ID: 4358421
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.
    Goldstein NS; Kestin LL; Vicini FA
    Cancer; 2001 Aug; 92(4):738-47. PubMed ID: 11550142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy.
    King TA; Ganaraj A; Fey JV; Tan LK; Hudis C; Norton L; Cody HS; Borgen PI
    Cancer; 2004 Sep; 101(5):926-33. PubMed ID: 15329899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductal lavage in patients undergoing mastectomy for mammary carcinoma: a correlative study.
    Brogi E; Robson M; Panageas KS; Casadio C; Ljung BM; Montgomery L
    Cancer; 2003 Nov; 98(10):2170-6. PubMed ID: 14601086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic influence of incisional biopsy or excisional biopsy in breast cancer patients treated by radical mastectomy].
    Su Y; Rui JA; Wang CF
    Zhonghua Wai Ke Za Zhi; 1987 Oct; 25(10):573-5, 612. PubMed ID: 2835214
    [No Abstract]   [Full Text] [Related]  

  • 19. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
    Renshaw AA; Derhagopian RP; Martinez P; Gould EW
    Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.
    Fisher ER; Costantino J; Fisher B; Palekar AS; Paik SM; Suarez CM; Wolmark N
    Cancer; 1996 Oct; 78(7):1403-16. PubMed ID: 8839545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.